These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 38786070)

  • 21. Advances in sickle cell therapies in the hydroxyurea era.
    Field JJ; Nathan DG
    Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S37-42. PubMed ID: 25549232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Options for Sickle Cell Disease.
    Meier ER
    Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voxelotor: A Novel Treatment for Sickle Cell Disease.
    Herity LB; Vaughan DM; Rodriguez LR; Lowe DK
    Ann Pharmacother; 2021 Feb; 55(2):240-245. PubMed ID: 32674605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.
    Pagare PP; Rastegar A; Abdulmalik O; Omar AM; Zhang Y; Fleischman A; Safo MK
    Expert Opin Ther Pat; 2022 Feb; 32(2):115-130. PubMed ID: 34657559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curative Therapies for Sickle Cell Disease.
    Kaviany S; Barnawi Z; LaBelle J
    Pediatr Ann; 2024 Feb; 53(2):e56-e61. PubMed ID: 38302122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.
    Ansari J; Moufarrej YE; Pawlinski R; Gavins FNE
    Expert Rev Hematol; 2018 Jan; 11(1):45-55. PubMed ID: 29207881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease.
    Ferraresi M; Panzieri DL; Leoni S; Cappellini MD; Kattamis A; Motta I
    Eur J Pediatr; 2023 Jun; 182(6):2509-2519. PubMed ID: 36997768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Therapies for the Management of Sickle Cell Disease.
    Rai P; Ataga KI
    F1000Res; 2020; 9():. PubMed ID: 32765834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Sickle Cell Disease Treatments.
    Pavan AR; Dos Santos JL
    Curr Med Chem; 2021; 28(10):2008-2032. PubMed ID: 32520675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for sickle cell disease: where we are now?
    Kanter J; Falcon C
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):174-180. PubMed ID: 34889358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End Organ Affection in Sickle Cell Disease.
    Bathla T; Lotfollahzadeh S; Quisel M; Mehta M; Malikova M; Chitalia VC
    Cells; 2024 May; 13(11):. PubMed ID: 38891066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to rethink haemoglobin threshold guidelines in sickle cell disease.
    Ballas SK; Kuypers FA; Gordeuk VR; Hankins JS; Thompson AA; Vichinsky E
    Br J Haematol; 2021 Nov; 195(4):518-522. PubMed ID: 34131897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges - review article.
    Youssry I; Ayad N
    Ann Hematol; 2024 Aug; 103(8):2613-2619. PubMed ID: 37867187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigational curative gene therapy approaches to sickle cell disease.
    Williams DA; Esrick E
    Blood Adv; 2021 Dec; 5(23):5452. PubMed ID: 34905048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and emerging drug treatment strategies to tackle sickle cell anemia.
    Persaud Y; Leonard A; Rai P
    Expert Opin Emerg Drugs; 2024 Jul; ():1-20. PubMed ID: 38988318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment?
    Matte A; Cappellini MD; Iolascon A; Enrica F; De Franceschi L
    Expert Opin Investig Drugs; 2020 Jan; 29(1):23-31. PubMed ID: 31847604
    [No Abstract]   [Full Text] [Related]  

  • 38. Sickle Cell Disease: A Brief Update.
    Azar S; Wong TE
    Med Clin North Am; 2017 Mar; 101(2):375-393. PubMed ID: 28189177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sickle cell disease: current treatment and emerging therapies.
    Neumayr LD; Hoppe CC; Brown C
    Am J Manag Care; 2019 Nov; 25(18 Suppl):S335-S343. PubMed ID: 31809007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.